Evidence map›Paper›PMID 33154829›Full record

ArticleJournal of breast cancer2020

Patient Perception of Telehealth Services for Breast and Gynecologic Oncology Care during the COVID-19 Pandemic: A Single Center Survey-based Study.

Brittney S Zimmerman, Danielle Seidman, Natalie Berger, Krystal P Cascetta, Michelle Nezolosky, Kara Trlica, Alisa Ryncarz, Caitlin Keeton, Erin Moshier, Amy Tiersten

Abstract read
In one paragraph

Article in Journal of breast cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Racial/Ethnic Disparities in Telemedicine Utilization and Satisfaction Among Breast Cancer Patients During the COVID-19 Pandemic: A Mixed-Methods Analysis.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2024
    Article
  13. Article
  14. Breast cancer care amidst a pandemic: a scoping review to understand the impact of coronavirus disease 2019 on health services and health outcomes.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2023
    Article
  15. Adult Hematology/Oncology Patient Perspectives on Telemedicine Highlight Areas of Focus for Future Hybrid Care Models.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2023
    Article
  16. Disruption in Cancer Care During Early Survivorship due to the COVID-19 Pandemic and Patient Satisfaction with Telemedicine.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Brittney S ZimmermanDepartment of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-9737-9197
Danielle SeidmanDepartment of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0003-2696-7394
Natalie BergerDepartment of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-6922-6866
Krystal P CascettaDepartment of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-7302-9117
Michelle NezoloskyDepartment of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-7194-3255
Kara TrlicaDepartment of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-9689-7892
Alisa RyncarzDepartment of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-0786-144X
Caitlin KeetonDepartment of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0003-2922-2996
Erin MoshierDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-8912-4709
Amy TierstenDepartment of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-4054-9140

Funding

THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANTP30CA196521 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ramon E Parsons · 2015 to 2026
$35.4M
NCI NIH HHS P30 CA196521
6 · The paper itself

Abstract

Prior to the coronavirus disease 2019 (COVID-19) pandemic, telehealth was rarely utilized for oncologic care in metropolitan areas. Our large New York City based outpatient breast/gynecologic cancer clinic administered an 18-question survey to patients from March to June 2020, to assess the perceptions of the utility of telehealth medicine. Of the 622 patients, 215 (35%) completed the survey, and of the 215 respondents, 74 (35%) had participated in a telehealth visit. We evaluated the use of telehealth services using the validated Service User Technology Acceptability Questionnaire. Sixty-eight patients (92%) reported that telehealth services saved them time, 54 (73%) reported telehealth increased access to care, and 58 (82%) reported telehealth improved their health. Overall, 67 (92%) of patients expressed satisfaction with the use of telehealth services for oncologic care during the COVID-19 pandemic. Telehealth services should be carefully adopted as an addition to in-person clinical care of patients with cancer.

Indexed as

Breast neoplasmsCoronavirusQuality of lifeTelemedicine

Identifiers

PMID33154829
PMCPMC7604367

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.